Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis (PAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00552461

Recruitment Status : Unknown

Verified May 2008 by East Carolina University.
Recruitment status was: Recruiting

First Posted : November 2, 2007

Last Update Posted : May 9, 2008

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Genentech, Inc.

Information provided by:

East Carolina University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	July 2009
Estimated Study Completion Date :	December 2009

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Kavuru MS, Malur A, Marshall I, Barna BP, Meziane M, Huizar I, Dalrymple H, Karnekar R, Thomassen MJ. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J. 2011 Dec;38(6):1361-7. doi: 10.1183/09031936.00197710. Epub 2011 Apr 8.

To Top